Association of alpha-1 blocker (ɑ-1B) on coronavirus disease (COVID-19) susceptibility and severity

First published 11/07/2020

Last updated 22/02/2024

EU PAS number:

EUPAS36231

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

alpha_blocker_study_protocol (1)

English (584.75 KB - PDF) View document

Updated protocol

alpha_blocker_study_protocol

First published: 22/02/2024

English (254.48 KB - PDF) View document

Study results

Study report

Other information

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

Signed checklist for study protocols

ENCePPChecklistforStudyProtocols (1)

English (224.47 KB - PDF) View document

Association of alpha-1 blocker (ɑ-1B) on coronavirus disease (COVID-19) susceptibility and severity

Secondary tabs

Share this page